Cholesterol drug may help children with malaria

12/28/2012 | Voice of America

An international team of researchers found that adding the cholesterol drug lovastatin to malaria treatment chloroquine could prevent the late cognitive problems associated with cerebral malaria, according to a mouse model study published in the journal PLoS Pathogens. Lead researcher Dr. Guy Zimmerman of the University of Utah says lovastatin should be added to treatments for malaria.

View Full Article in:

Voice of America

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC